Advertisement Banner
Skip to content

EHP

Solar UV Doses of Young Americans and Vitamin D3 Production

Dianne Eyvonn Godar1, Stanley James Pope2, William Burgess Grant3, Michael Francis Holick4

1 U.S. Food and Drug Administration, Center for Devices and Radiological Health, Rockville, Maryland, USA, 2 Sun Systems and Service, Inc., Oak Park, Michigan, USA, 3 Sunlight, Nutrition and Health Research Center, San Francisco, California, USA, 4 Boston University School of Medicine, Boston, Massachusetts, USA



Environ Health Perspect 120:139-143 (2012). http://dx.doi.org/10.1289/ehp.1003195 [online 18 August 2011]

Research Article

Abstract

Background: Sunlight contains ultraviolet B (UVB) radiation (290–315 nm) that affects human health in both detrimental (skin cancers) and beneficial (vitamin D3) ways. Serum 25-hydroxyvitamin D concentrations from young Americans (≤ 19 years) show that many have deficient (< 50 nmol/L, 20 ng/mL) or insufficient (< 75 nmol/L, 30 ng/mL) vitamin D levels, indicating that they are not getting enough sun exposure. Those findings are in conflict with some calculated, published values that suggest people make “ample” vitamin D3 (~ 1,000 IU/day) from their “casual,” or everyday, outdoor exposures even if they diligently use sunscreens with sun protection factor (SPF) 15.

Objective: We estimated how much vitamin D3 young Americans (n = ~ 2,000) produce from their everyday outdoor ultraviolet doses in the North (45°N) and South (35°N) each season of the year with and without vacationing.

Methods: For these vitamin D3 calculations, we used geometric conversion factors that change planar to whole-body doses, which previous calculations did not incorporate.

Results: Our estimates suggest that American children may not be getting adequate outdoor UVB exposures to satisfy their vitamin D3 needs all year, except some Caucasians during the summer if they do not diligently wear sunscreens except during beach vacations.

Conclusion: These estimates suggest that most American children may not be going outside enough to meet their minimal (~ 600 IU/day) or optimal (≥ 1,200 IU/day) vitamin D requirements.

Key words: cancer, environment, sunlight, sunscreen, vitamin D

Address correspondence to D.E. Godar, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave. (HFZ-120), Silver Spring, MD 20993-0002 USA. Telephone: (301) 796-0299. Fax: (301) 796-9826. E-mail: Dianne.Godar@FDA.HHS.GOV

W.B.G. receives funding from the UV Foundation (McLean, VA, USA), the Sunlight Research Forum (Veldhoven, Netherlands), Bio-Tech-Pharmacal (Fayetteville, AR, USA), the Vitamin D Council (San Luis Obispo, CA, USA), and the Danish Sunbed Federation (Middelfart, Denmark). M.F.H. receives funding from the UV Foundation (McClean, VA, USA). The other authors declare they have no actual or potential competing financial interests.

We thank A.D. Lucas for critically reviewing the manuscript. S.J.P. and W.B.G. are the directors of Sun Systems and Service, Inc., and Sunlight, Nutrition and Health Research Center, respectively.

Received 09 November 2010; accepted 18 August 2011; online 18 August 2011.

Ultraviolet (UV) radiation (290–400 nm) in sunlight can affect people’s health in both detrimental and beneficial ways. Short-term detrimental health effects include sunburn and immune suppression, and long-term detrimental health effects include cataracts, photoaging, and DNA damage with mutations that can lead to nonmelanoma and melanoma skin cancers. Beneficial health effects of UV radiation include medical detection and treatments of diseases such as cancers; possible reduction in the mortality from some cancers, including colon cancer (Garland et al. 1989), breast and prostate cancer (Freedman et al. 2002), and melanoma (Berwick et al. 2005); and vitamin D3 production (Holick et al. 1980).

Children may need more vitamin D3 than amounts recently recommended (600 IU/day) by the Institute of Medicine (2011) to maintain healthy muscles (Pfeifer et al. 2002), bones (Holick 2007), and general health (Heaney and Holick 2011; Holick 2011). For example, the risk of type 1 diabetes may be significantly reduced in children if they take 2,000 IU/day of vitamin D supplements early in life (Ponsonby et al. 2009; Zipitis and Akobeng 2008). Conversely, there is some evidence that infants who develop rickets, a consequence of vitamin D deficiency, are at increased risk of type 1 diabetes mellitus (Hyppönen et al. 2001). Thus, correct levels of vitamin D may prevent or reduce the occurrence of type 1 diabetes mellitus (Harris 2005).

For most children, the major source of vitamin D3 comes from exposing their skin to sunlight (Glerup et al. 2000). In animals, yeast, fungi, and plants, sunlight forms either vitamin D3 or D2, both of which may be equally effective in maintaining human serum levels of 25-hydroxyvitamin D [25(OH)D; D represents both D2 and D3; Holick et al. 2008]. Vitamin D3 production occurs in human skin when ultraviolet B (UVB; 290–315 nm) photons convert 7-dehydrocholesterol, or provitamin D3, made by keratinocytes to previtamin D3 (MacLaughlin et al. 1982), which thermally isomerizes to vitamin D3 (Holick et al. 1995b). Vitamin D3 that forms in the skin and vitamin D2 or D3 from dietary sources are carried into the bloodstream by vitamin D–binding protein, an alpha1 globulin. The liver enzyme vitamin D-25-hydroxylase hydroxylates it to 25(OH)D, and then the kidney enzyme 25(OH)D-1-α-hydroxylase further hydroxylates it to the hormonally active form, 1,25-dihydroxyvitamin D [1,25(OH)2D]. In addition to liver and kidney cells, most cells in the body can convert either vitamin D or 25(OH)D to 1,25(OH)2D, including colon, breast, lung, and prostate cells, keratinocytes, and melanoma cells (Reichrath et al. 2007; Zehnder et al. 2001).

Most people in the United States do not get sufficient vitamin D from dietary sources [fortified foods and drinks (milk and orange juice) and supplements] (Moore et al. 2004), so sunlight-derived vitamin D is their primary source. However, because the incidence of skin cancers is increasing at an alarming rate, public health organizations have warned people, especially children, to stay out of the sunlight whenever possible and to wear protective clothing, sunglasses, and sunscreens with sun protection factor (SPF) 15 or higher while outdoors from 1000 hours to 1600 hours. (e.g., Goldman 2002; Skin Cancer Foundation 2011; U.S. Environmental Protection Agency 2011). Although sunscreens with SPF ≥ 15 almost completely inhibit vitamin D3 production (Holick et al. 1995a; Matsuoka et al. 1988), the American Academy of Dermatology has concluded that people will still make “ample” vitamin D3 (≥ 1,000 IU/day) because they get plenty of “casual,” or everyday, outdoor UV exposure (Lim et al. 2005). However, an evaluation of serum 25(OH)D revealed that about half of all American children have either deficient or insufficient levels (Gordon et al. 2004, 2008; Looker et al. 2002, 2008; Mansbach et al. 2009).

To clarify whether “casual” sunlight exposures make ample vitamin D3, we calculated the amounts produced from everyday outdoor UV dose estimates (Godar 2001) according to sex, age, Fitzpatrick skin type (Fitzpatrick 1988), clothing (Matsuoka et al. 1992), and season for children in the northern and southern United States.

Materials and Methods

We extracted and calculated erythemally weighted UV doses (Godar et al. 2001) from a 2-year survey of 9,386 Americans residing in the contiguous United States, including about 2,000 children (≤ 19 years) (Godar 2001). We converted the average daily standard erythemal dose (SED; a UV dose weighted by the erythemal action spectrum, so that it is independent of the spectral output of the source and the individual’s skin type; 1 SED = 100 J/m2) for each season to standard vitamin D3 doses (SVDs) relative to the horizontal plane using action spectrum conversion factors (ASCFs; Pope et al. 2008), and then converted those planar dose estimates to human body doses using geometric conversion factors (GCFs; Pope and Godar 2010). An action spectrum shows the relative effectiveness of each wavelength (nanometers) toward some end point that can be used to weight spectral outputs of different sources like the sun or a tanning bed in order to estimate amounts produced—for example, erythemal response (sunburn) or vitamin D3 production.

The ASCFs account for the differences between wavelength contributions estimated by the erythemal action spectrum and the previtamin D action spectrum toward previtamin D3 production. To derive the SVD for a given season and latitude, we multiplied the SED per day by the appropriate ASCF:

SVD = SED/day × ASCF. [1]

ASCFs for the northern (45°N) and southern (35°N) United States are 1.034 and 1.104 for summer, 0.879 and 1.029 for fall, 0.565 and 0.842 for winter, and 0.9 and 1.049 for spring, respectively (Pope et al. 2008).

SVDs, which represent horizontal plane or planar doses, are converted to whole-body doses using GCFs based on a full-cylinder model representing the human body (Pope and Godar 2010). GCFs for the northern United States (45°N) are 0.434 during the summer and spring and 0.508 during the winter and fall; GCFs for the southern United States (35°N) are 0.417 during the summer and spring and 0.484 during the winter and fall. The average vitamin D3 dose (VDD) per day is derived by multiplying the SVD by the appropriate GCF:

VDD = SVD × GCF. [2]

To estimate the amount of vitamin D3 a person makes from outdoor UV exposures when engaged in different activities, we first determined how much vitamin D3 a person would make from an erythemally weighted UV dose with uniform geometry, such as the UV dose from a tanning bed. For example, a female with Fitzpatrick skin type II (Caucasian; Fitzpatrick 1988) with a whole-body exposure to one minimum erythemal dose (MED), or the amount of UV needed to barely turn skin pink after 24 hr, in a tanning bed with a weighted spectral distribution similar to the midday summer sun at approximately 35°N produces the equivalent of an oral dose of approximately 15,500 IU vitamin D2 or D3 (Holick et al. 2008). Because melanin impedes the penetration of UVB and reduces vitamin D3 production (Clemens et al. 1982; Matsuoka et al. 1991), the UV dose required to achieve an MED and make the same amount of vitamin D varies by skin type. For Fitzpatrick skin type II (Fitzpatrick 1988), 1 MED is defined as 250–350 J/m2, and so we refer to skin type II as 300 J/m2 or 3 SED. For a whole-body exposure, a person with skin type II with an MED of 320 J/m2 will make approximately 15,500 IU/MED or approximately 4,900 IU/SED. Similarly, 1 MED is 300–500 J/m2 or 4 SED (average) for skin type III (olive skin tone, Hispanic or Asian), 450–600 J/m2 or 5.25 SED for skin type IV (brown skin tone, e.g., Indian), 600–900 J/m2 or 7.5 SED for skin type V (light-skinned African American), and for skin type VI (dark-skinned African American), 600–2,000 J/m2 or approximately 13 SED. Consequently, for a given UVB dose, Caucasians with skin type II make at least two to three times more vitamin D3 than do African Americans with skin type V (Dong et al. 2010; Matsuoka et al. 1991) and 10–20 times more than do African Americans with skin type VI (Clemens et al. 1982). The ratio of vitamin D production for someone with skin type II compared with other skin types, referred to as the skin type factor (STF), is used to adjust predictions for each skin type: 3.2/3 for skin type II, 3.2/4 for type III, 3.2/5.25 for skin type IV, and 3.2/7.5 for skin type V. We did not calculate vitamin D values for skin type VI because they are below those of skin type V, which has very low values.

The amount of vitamin D3 people make from outdoor UV exposures also depends on how much skin they expose to the sun, or the percent body exposure (PBE). To get the best estimates of how much body area people expose or PBE during each season of the year, we used estimates for burn areas (Lund and Browder 1944). For example, we assumed that young adults would expose the face (4.5–7.8%), the front half of the neck (1%), and the front and back of both hands (5%) during all seasons of the year (PBE ~ 10.5–13.8%; Table 1) and would also expose the lower arms (6%) and lower legs (10–13%) during the spring and fall (PBE ~ 30%) and half of the upper arms (4%; short-sleeved/T-shirts) and half of the upper legs (7–9%; shorts/skirts) during the summer (PBE ~ 41–44%).

Table 1: Estimates of PBE for each season, by age (based on data from Lund and Browder 1944).

Table 1

Estimates of PBE for each season, by age (based on data from Lund and Browder 1944).

Download larger image (TIF File)

Because vitamin D3 production decreases with age (MacLaughlin and Holick 1985), we included an age factor (AF) in the calculations. Young adults (< 22 years of age), who have the highest ability to make vitamin D3, are assigned an AF = 1, and adults (≥ 22 years of age) are assigned fractions according to their age range (Godar et al. 2011). Therefore, the final equation for calculating the amount of vitamin D3 produced from an average everyday UV exposure during each season of the year is

ehp.1003195.e001[3]

For example, during the summer, a 4-year-old African-American girl with skin type V living near Atlanta, Georgia (~ 34°N), and wearing a T-shirt and short shorts (thus exposing ~ 40.8% of her body area; see Table 1) would get, on average, about 1 SED/day (Godar 2001) (~ 2 hr outdoors, scattered throughout the day) and would make about 397 IU of vitamin D3 per day [vitamin D3 (IU/day) = ([1.01 SED × 1.104] × 0.417) × (4,900 IU) × (3.2/7.5) × 0.408 × 1.0].

To account for sunscreen use, divide the estimate from Equation 3 by the SPF factor (Matsuoka et al. 1988). However, this assumes that sunscreens are used correctly, that is, that they are applied generously to the entire body before going outdoors and are reapplied every 2 hr.

To account for additional sun exposure during vacations, we recalculated estimates assuming that 2–3 weeks each summer were spent vacationing at approximately 40°N, as estimated by Godar et al. (2001), with the use of SPF 4 sunscreen or the equivalent only during beach vacations. In addition, we averaged exposures for four different types of vacations—beach, sightseeing, country, and home—and assumed that people would wear the least amount of clothing during a summer vacation (PBE ~ 50–90%), depending on the type of vacation.

Results

Table 1 shows estimates for PBE by different age groups during each season of the year, based on the data of Lund and Browder (1944). During the winter body exposure is highest in young children (≤ 5 years), and during the rest of the year body exposure is highest in teenagers (13–19 years). Adults (≥ 22 years) have the lowest PBE during all seasons. Note here that levels of vitamin D3 can increase during the summer by ≥ 30% (~ 500 IU/day) depending on clothing choice (data not shown).

Figure 1 shows estimates of the average amount of vitamin D3 made by children with Fitzpatrick skin type II according to season, age group, sex, diligent use of SPF 15 sunscreen, and residence in the northern or southern United States. According to our estimates, the minimum recommended daily dose of vitamin D (600 IU/day; Institute of Medicine 2011) is achieved by skin type II children in the northern United States only during the summer and only if they do not wear sunscreen with SPF ≥ 15 (Figure 1A). However, results suggest that most children with skin type II in the southern United States can get the recommended daily dose during the spring and summer if they do not wear sunscreen with SPF ≥ 15 (Figure 1B). Optimal vitamin D3 production (≥ 1,200 IU/day) is achieved primarily by a subset of children in the southern United States during the summer (Dong et al. 2010).

Figure 1: Average estimated vitamin D3 production by American children with skin type II according to age (years), sex, season, sunscreen use, and residence in the northern (45°N; A) or southern (35°N; B) United States.

Figure 1

Average estimated vitamin D3 production by American children with skin type II according to age (years), sex, season, sunscreen use, and residence in the northern (45°N; A) or southern (35°N; B) United States.

Download larger image (TIF File)

Figure 2 shows the average amount of vitamin D3 produced from everyday outdoor exposure according to skin type (II–V), season, and residence in the northern or southern United States for all children ≤ 19 years combined (without using sunscreen). Our estimates suggest that in the northern United States (Figure 2A), the minimum recommended daily dose of vitamin D3 (600 IU/day) is made by skin type II, III, and IV children only during the summer, and the optimal dose of ≥ 1,200 IU/day is not made during any season, regardless of skin type, except by a small subset of skin type II children during the summer (Figure 1A). In the southern United States (Figure 2B), we estimate that the minimum amount (600 IU/day) is achieved during the summer by children with skin types II, III, and IV and during the spring by children with skin type II only, whereas the optimum amount (≥ 1,200 IU/day) is achieved only by children with skin type II during the summer (Figure 2B). These findings suggest that everyday outdoor exposure for children with skin type III and skin type IV rarely provides their minimum vitamin D3 needs (~ 600 IU/day), and children with skin type V may never meet their minimum daily vitamin D needs.

Figure 2: Average estimated vitamin D3 produced in children (≤ 19 years of age) from everyday outdoor UV exposures in the northern (45°N; A) or southern (35°N; B) United States, according to Fitzpatrick skin type and season (without use of sunscreen with SPF ≥ 15).

Figure 2

Average estimated vitamin D3 produced in children (≤ 19 years of age) from everyday outdoor UV exposures in the northern (45°N; A) or southern (35°N; B) United States, according to Fitzpatrick skin type and season (without use of sunscreen with SPF ≥ 15).

Download larger image (TIF File)

Taking a 2- or 3-week summer vacation at 40°N during the summer increases the average estimated vitamin D3 production for children of all skin types but still may be insufficient to meet minimum or optimum requirements in children with skin type V because these are optimistic estimates (minimum clothing and maximum time outdoors and no sunscreens) [Figure 3; UV doses estimated by Godar et al. (2001)].

Figure 3: Average estimated vitamin D3 made by U.S. children (≤ 19 years of age) during the summer according to skin type and vacation length (at latitude ~ 40°N in the continental United States). We assumed people use the equivalent of SPF 4 sunscreen during beach vacations.

Figure 3

Average estimated vitamin D3 made by U.S. children (≤ 19 years of age) during the summer according to skin type and vacation length (at latitude ~ 40°N in the continental United States). We assumed people use the equivalent of SPF 4 sunscreen during beach vacations.

Download larger image (TIF File)

Discussion

Although our estimates assumed “optimistic” clothing scenarios for making vitamin D3, they raise the question as to whether American children are going outdoors enough to meet their minimum daily vitamin D requirements (600 IU/day; for blood levels of 20 ng/mL or 50 nmol/L) recommended by the Institute of Medicine (2011). The amount of time varies by season (Godar 2001). Based on the results of this analysis, it appears that most active Caucasian children of skin type II can make optimal amounts of vitamin D3 (≥ 1,200 IU/day for blood levels of 30 ng/mL or 75 nmol/L) during the summer, but only if they do not use sunscreens diligently except during beach vacations. However, children with darker skin may never achieve optimal production, whereas those with skin types III and IV may meet only minimum requirements during the summer, and children with very dark skin (type V) may meet their optimum requirements during the summer only if they take a 3-week beach vacation at latitudes lower than 40°N (approximate middle of the United States).

If children really need to achieve optimal blood levels of 30 ng/mL (~ 75 nmol/L), then they need at least twice the current recommendation, or about 1,200 IU/day of vitamin D. However, two recent studies, which examined > 25 children in each different skin type and sun exposure category, concluded that children need ≥ 2,000 IU/day from oral supplements (Maalouf et al. 2008), equivalent UV exposure, or a combination (Hall et al. 2010) to maintain blood levels of 25(OH)D > 75 nmol/L. If children really need ≥ 2,000 IU/day, then almost no one in the United States can make the needed amount of vitamin D3 from everyday sun exposure all year.

Overall, males go outside somewhat more than females, and children in the youngest age group (≤ 5 years) go outside somewhat more than do those in the other age groups (Godar 2001), so they make a little more vitamin D3, in agreement with the findings of three recent large U.S. studies (Ginde et al. 2009; Looker et al. 2008; Mansbach et al. 2009). Children spend approximately 1.6 ± 0.1 hr/day (weekdays and weekends averaged) outdoors during the summer (Godar 2001), giving them about two-thirds of an MED for a skin type II body exposure (Pope and Godar 2010). If the children are Caucasian with skin type II and wear minimal clothing (e.g., wear a diaper, shorts, or a bathing suit, or females wear tank or halter tops and short shorts, or males do not wear a shirt and wear short shorts), then they can make at least 30% more than the estimated vitamin D3 (~ 500 IU/day; data not shown). In contrast, if people wear sunscreen with SPF ≥ 15, they will make virtually no vitamin D3 (Holick et al. 1995a; Matsuoka et al. 1988).

Our estimates are consistent with reports of vitamin D deficiency (< 50 nmol/L, < 20 ng/mL) and insufficiency (< 75 nmol/L, < 30 ng/mL) among children and adolescents in the United States. For example, the Third National Health and Nutrition Examination Survey (NHANES III 1988–1994) study showed that 13% of male and 29% of female adolescents (12–19 years) had deficient levels and that 25% of male and 47% of female adolescents had insufficient levels of 25(OH)D during the winter (Looker et al 2002). During the summer, 8% of males and 13% of females had deficient levels and 21% of males and 28% of females had insufficient levels of 25(OH)D. In addition, the percentage of children with deficient levels during the winter increased with increasing skin color: skin types I/II, 8% male and 15% female; skin types III/IV, 18% male and 41% female; skin types V/VI, 53% male and 70% female. NHANES 2000–2004 data indicated that approximately 20% more Americans were vitamin D deficient compared with the previous decade, partly because of increased sun protection (Ginde et al. 2009; Looker et al. 2008; Mansbach et al. 2009). A study in Augusta, Georgia (33°N), examined 559 adolescents and found that during the winter, 3.9% of male and 2.6% of female adolescents with skin type II had deficient levels of 25(OH)D, and 46.9% of male and 73.8% of female adolescents had insufficient levels (Dong et al. 2010). The same study also showed that during the winter, 84% of African Americans with skin types V and VI had deficient levels of 25(OH)D and 98% had insufficient levels, whereas during the summer 56% had deficient and 88% had insufficient levels. A study in Pittsburgh, Pennsylvania (40°N), of 41 preadolescent African Americans (6–10 years of age) found that 49% had deficient 25(OH)D levels (Rajakumar et al. 2005). The recent resurgence of rickets in breast-fed African-American infants in several southern states suggests that vitamin D deficiency is on the rise in the United States (Kreiter et al. 2000). Similar insufficient and deficient levels of 25(OH)D are found in young adults in the southern hemisphere at comparable latitudes (35–46°S; Rockell et al. 2005), where they get UV doses similar to those in the United States (Godar 2005). Insufficient sun exposure in adults is also a concern, particularly because the ability to make vitamin D decreases with age; seniors > 70 years of age can make only 25–50% of what a child can make (MacLaughlin and Holick 1985). Deficient and insufficient vitamin D levels from insufficient sun exposure are a worldwide problem with serious health consequences (Holick and Chen 2008).

Conversely, serious health consequences can also arise from too much sun exposure. Too much UV radiation can lead to the formation of three types of skin cancers: squamous cell carcinoma, basal cell carcinoma, and melanoma. Paradoxically, regular, moderate sun exposure may reduce the incidence of fatal melanoma (Godar et al. 2009). Melanoma cells have been shown to convert vitamin D3 to 1,25(OH)2D in vitro (Reichrath et al. 2007), and it has been reported that 1,25(OH)2D can reduce tumor growth and decrease the number and size of skin tumors and melanoma xenografts in animal models (Eisman et al. 1987) and inhibit in vivo pulmonary metastasis (Yudoh et al. 1999) and angiogenesis (Mantell et al. 2000). Further, continual rather than intermittent outdoor UV exposure has been associated with a reduced incidence of melanoma (Gandini et al. 2005; Kennedy et al. 2003) relative to the cumulative annual UV dose (Godar 2005), and sun exposure has been associated with increased survival in melanoma patients (Berwick et al. 2005). Thus, it has been suggested that promoting protection from all midday UV exposures and advising the diligent use of sunscreens with SPF ≥ 15 may paradoxically be promoting the incidence of melanoma (Godar et al. 2009; Gorham et al. 2007).

In conclusion, our estimates suggest that many children may not get enough sun exposure to meet their minimum daily vitamin D requirements. However, additional research is needed to confirm our estimates and to improve our understanding of the net benefits and risks of sun exposure to children’s health.

Attached Files

PDF Version

References

  1. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, et al. 2005. Sun exposure and mortality from melanoma. J Natl Cancer Inst 97:195–199.
  2. Clemens TL, Adams JS, Henderson SL, Holick MF. 1982. Increased skin pigment reduces the capacity to synthesize vitamin D3. Lancet 1:74–76.
  3. Dong Y, Pollock N, Stallmann-Jorgensen IS, Gutin B, Lan L, Chen TC, et al. 2010. Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics 125:1104–1111.
  4. Eisman JA, Barkla DH, Tutton PJ. 1987. Suppression of in vivo growth of human cancer solid tumor xenografts by 1, 25-dihydroxyvitamin D3. Cancer Res 47:21–25.
  5. Fitzpatrick TB. 1988. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869–871.
  6. Freedman DM, Dosemeci M, McGlynn K. 2002. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59:257–262.
  7. Gandini S, Sera F, Cattaruza MS, Pasquini P, Picconi O, Boyle P, et al. 2005. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45–60.
  8. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. 1989. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176–1178.
  9. Ginde AA, Liu MC, Camargo CA Jr. 2009. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169:626–632.
  10. Glerup H, Mikkelsen K, Poulsen L, Has E, Overbeck S, Thomsen J, et al. 2000. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 247:260–268.
  11. Godar DE. 2001. UV doses of American children and adolescents. Photochem Photobiol 74:787–793.
  12. Godar DE. 2005. UV doses worldwide. Photochem Photobiol 81:736–749.
  13. Godar DE, Landry R, Lucas AD. 2009. Increased UVA exposures and decreased cutaneous vitamin D(3) levels may be responsible for the increasing incidence of melanoma. Med Hypotheses 72:434–443.
  14. Godar DE, Pope SJ, Grant WB, Holick MF. 2011. Solar UV doses of adult Americans and vitamin D3 production. Dermatoendocrinology 3:((4):)243–250.
  15. Godar DE, Wengraitis SP, Shreffler J, Sliney DH. 2001. UV doses of Americans. Photochem Photobiol 73:621–629.
  16. Goldman EI. 2002. Skin cancer messages target teens. Skin Allergy News 33(6):1–4.
  17. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. 2004. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158:531–537.
  18. Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, et al. 2008. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162:505–512.
  19. Gorham ED, Mohr SB, Garland CF, Chaplin G, Garland FC. 2007. Do sunscreens increase risk of melanoma in populations residing at higher latitudes? Ann Epidemiol 17:956–963.
  20. Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, et al. 2010. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140:542–550.
  21. Harris SS. 2005. Vitamin D in type 1 diabetes prevention. J Nutr 135:323–325.
  22. Heaney RP, Holick MF. 2011. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26(3):455–457.
  23. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357:266–281.
  24. Holick MF. 2011. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 12:4–18.
  25. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. 2008. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93:677–681.
  26. Holick MF, Chen TC. 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086S.
  27. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr, Anderson RR, et al. 1980. Photosynthesis of pre-vitamin D3 in human skin and the physiological consequences. Science 210:203–205.
  28. Holick MF, Matsuoka LY, Wortsman J. 1995a. Regular use of sunscreen on vitamin D levels. Arch Dermatol 131:1337–1339.
  29. Holick MF, Tian XQ, Allen M. 1995b. Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci USA 92:3124–3126.
  30. Hyppönen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. 2001. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503.
  31. Institute of Medicine 2011. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC:National Academies Press.
  32. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. 2003. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 120:1087–1093.
  33. Kreiter SR, Schwartz RP, Kirkman HN Jr, Charlton PA, Calikoglu AS, Davenport ML. 2000. Nutritional rickets in African American breast-fed infants. J Pediatr 137:153–157.
  34. Lim HW, Gilchrest BA, Cooper KD, Bischoff-Ferrari HA, Rigel DR, Cyr WH, et al. 2005. Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 52:868–876.
  35. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. 2002. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771–777.
  36. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. 2008. Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88:1519–1527.
  37. Lund CC, Browder NC. 1944. The estimation of areas of burns. Surg Gynecol Obstet 79:352–358.
  38. Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z, et al. 2008. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in schoolchildren. J Clin Endocrinol Metab 93:2693–2701.
  39. MacLaughlin JA, Anderson RR, Holick MF. 1982. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216:1001–1003.
  40. MacLaughlin JA, Holick MF. 1985. Aging decreases the capacity of human skin to make vitamin D3. J Clin Invest 76:1536–1538.
  41. Mansbach JM, Ginde AA, Camargo CA Jr. 2009. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 124:1404–1410.
  42. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 2000. 1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res 87:214–220.
  43. Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Holick MF. 1992. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 75:1099–1103.
  44. Matsuoka LY, Wortsman J, Haddad JG, Kolm P, Hollis BW. 1991. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 127:536–538.
  45. Matsuoka LY, Wortsman J, Hanifan N, Holick MF. 1988. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol 124:1802–1804.
  46. Moore CE, Murphy MM, Keast DR, Holick MF. 2004. Vitamin D intake in the United States. J Am Diet Assoc 104:980–983.
  47. Pfeifer M, Begerow B, Minne HW. 2002. Vitamin D and muscle function. Osteoporos Int 13:187–194.
  48. Ponsonby AL, Cameron F, Saffery R, Pezic A, Wong N, Craig J, et al. 2009. A case-sibling assessment of the association between skin pigmentation and other vitamin D-related factors and type 1 diabetes mellitus. Photochem Photobiol 85:1267–1270.
  49. Pope SJ, Godar DE. 2010. Solar UV geometric conversion factors: horizontal plane to cylinder model. Photochem Photobiol 86:457–466.
  50. Pope SJ, Holick MF, Mackin S, Godar DE. 2008. Action spectrum conversion factors that change erythemally weighted to previtamin D3-weighted UV doses. Photochem Photobiol 84:1277–1283.
  51. Rajakumar K, Fernstrom JD, Janosky JE, Greenspan SL. 2005. Vitamin D insufficiency in preadolescent African-American children. Clin Pediatr (Phila) 44:683–692.
  52. Reichrath J, Rech M, Moeini M, Meese E, Tilgen W, Seifert M.. 2007. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther 6:48–55.
  53. Rockell JE, Green TJ, Skeaff CM, Whiting SJ, Taylor RW, Williams SM, et al. 2005. Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5–14 y. J Nutr 135:2602–2608.
  54. Skin Cancer Foundation 2011. Skin Cancer Facts. Available: http://www.skincancer.org/Skin-Cancer-Fa​cts/ [accessed 1 January 2011]
  55. U.S. Environmental Protection Agency 2011. SunWise Kids. Available: http://www.epa.gov/sunwise/kids.html [accessed 1 January 2011]
  56. Yudoh K, Matsuno H, Kimura T.. 1999. 1alpha,25-Dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. J Lab Clin Med 133:120–128.
  57. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. 2001. . J Clin Endocrinol Metab 86:888–894.
  58. Zipitis CS, Akobeng AK. 2008. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517.

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien